Apex Labs
Laboratory documentation
Certificate of Analysis
- Product
- Retatrutide
- Batch / Lot
- Feb 26
- Published / tested
- 22 Sep 2026
Total quantity19.7 mg
Purity99.24%
IdentityRETA-20
Test Results
Active| Sample | Test | Specification | Result | Status |
|---|---|---|---|---|
| RETA-20 | Potency | Report Only | 19.7 mg | Reported |
| RETA-20 | Purity | Report Only | 99.24% | Reported |
| RETA-20 | ID | Report Only | Confirmed | Confirmed |
Apex Labs
Job Number: 1362
Report Version: 2
Date Received: 15 Sep 2026
Date Reported: 22 Sep 2026
Temperature on Receipt: 23°C
Storage Conditions: Refrigerated
Sample Comments: None
Test Method: HPLC-Peptides
Certificate and analytical information relates to the specific sample and batch identified in the corresponding report. Results should not be interpreted as applying to other batches unless specifically stated.
Products supplied by British Dragon Pharmaceuticals are intended for laboratory research and analytical purposes. Product information and supporting documentation are provided for research-reference purposes and do not constitute individual medical advice.